Haanen JB - Search Results

1

Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigen.

Bos R, van Duikeren S, Morreau H, Franken K, Schumacher TN, Haanen JB, van der Burg SH, Melief CJ, Offringa R. Bos R, et al. Among authors: haanen jb. Cancer Res. 2008 Oct 15;68(20):8446-55. doi: 10.1158/0008-5472.CAN-08-1864. Cancer Res. 2008. PMID: 18922918

2

Systemic T cell expansion during localized viral infection.

Haanen JB, Toebes M, Cordaro TA, Wolkers MC, Kruisbeek AM, Schumacher TN. Haanen JB, et al. Eur J Immunol. 1999 Apr;29(4):1168-74. doi: 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J. Eur J Immunol. 1999. PMID: 10229083 Free article.

3

Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.

Haanen JB, Wolkers MC, Kruisbeek AM, Schumacher TN. Haanen JB, et al. J Exp Med. 1999 Nov 1;190(9):1319-28. doi: 10.1084/jem.190.9.1319. J Exp Med. 1999. PMID: 10544203 Free PMC article.

4

Tracing and characterization of the low-avidity self-specific T cell repertoire.

de Visser KE, Cordaro TA, Kioussis D, Haanen JB, Schumacher TN, Kruisbeek AM. de Visser KE, et al. Among authors: haanen jb. Eur J Immunol. 2000 May;30(5):1458-68. doi: 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 10820394 Free article.

5

In situ detection of virus- and tumor-specific T-cell immunity.

Haanen JB, van Oijen MG, Tirion F, Oomen LC, Kruisbeek AM, Vyth-Dreese FA, Schumacher TN. Haanen JB, et al. Nat Med. 2000 Sep;6(9):1056-60. doi: 10.1038/79573. Nat Med. 2000. PMID: 10973329 No abstract available.

6

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.

Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, Haanen JB, Mutis T, Goulmy E. Dickinson AM, et al. Among authors: haanen jb. Nat Med. 2002 Apr;8(4):410-4. doi: 10.1038/nm0402-410. Nat Med. 2002. PMID: 11927949

7

Optimizing the efficacy of epitope-directed DNA vaccination.

Wolkers MC, Toebes M, Okabe M, Haanen JB, Schumacher TN. Wolkers MC, et al. Among authors: haanen jb. J Immunol. 2002 May 15;168(10):4998-5004. doi: 10.4049/jimmunol.168.10.4998. J Immunol. 2002. PMID: 11994451

8

Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.

Verra NC, Jorritsma A, Weijer K, Ruizendaal JJ, Voordouw A, Weder P, Hooijberg E, Schumacher TN, Haanen JB, Spits H, Luiten RM. Verra NC, et al. Among authors: haanen jb. Cancer Res. 2004 Mar 15;64(6):2153-61. doi: 10.1158/0008-5472.can-03-1339. Cancer Res. 2004. PMID: 15026357

9

On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients.

van Oijen M, Bins A, Elias S, Sein J, Weder P, de Gast G, Mallo H, Gallee M, Van Tinteren H, Schumacher T, Haanen J. van Oijen M, et al. Clin Cancer Res. 2004 Jul 15;10(14):4754-60. doi: 10.1158/1078-0432.CCR-04-0260. Clin Cancer Res. 2004. PMID: 15269149

10

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.

Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN, Haanen JB. Bins AD, et al. Among authors: haanen jb. Nat Med. 2005 Aug;11(8):899-904. doi: 10.1038/nm1264. Epub 2005 Jun 19. Nat Med. 2005. PMID: 15965482 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

430 results

Search Page